Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
TG101209
Cat. No.:
OB0225LY-0370
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
TG101209 is a selective inhibitor that acts on specific targets in the signal transduction pathway and is biocompatible.
Synonym:
936091-14-4; TG-101209; TG 101209; N-tert-Butyl-3-[[5-methyl-2-[4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide; N-tert-Butyl-3-(5-methyl-2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-ylamino)benzenesulfonamide; N-tert-Butyl-3-[(5-methyl-2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)amino]benzenesulfonamide
CAS No.:
936091-14-4
Compound CID:
16722832
Formula:
C26H35N7O2S
Formula Weight:
509.67
Specification
Relative Density:
1.250 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
TG101209 can be used to study the mechanisms of tumor cell proliferation or play an important role in the inflammatory response.
Library Information
Targets:
JAK family; FLT family; RET kinase
Receptors:
FLT3; JAK2; JAK3; RET
Pathways:
Chromatin/Epigenetic; JAK/STAT signaling; Stem cells; Angiogenesis; Tyrosine kinase/adaptors; Autophagy; Apoptosis
Plate Number:
AOCL-5
Plate Location:
g5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
94 mg/mL; 184.4 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
ALogP:
4.659
HBA_Count:
4
HBD_Count:
3
Rotatable Bond:
8
